{
    "course title": "26436 Pharmaceutical Drug Development",
    "Danish title": "Lægemiddeludviklingsprocessen",
    "Language of instruction": "English",
    "Point( ECTS )": "10",
    "Course type": "MSc\nOffered as a single course\nGeneral competence course (MSc), Pharmaceutical Design and Engineering\nProgramme specific course (MSc), see more\n\n\n\n\nTechnological specialization course (MSc), Applied Chemistry\nTechnological specialization course (MSc), Biomaterial Engineering for Medicine\nTechnological specialization course (MSc), Chemical and Biochemical Engineering",
    "Schedule": "Autumn E1 (Mon 8-12, Thurs 13-17)",
    "Location": "Campus Lyngby",
    "Scope and form": "Lectures, exercises and group work.",
    "Duration of Course": "13 weeks",
    "Date of examination": "E1A, E1B will also be used. Exams may be hold in parallel sessions.",
    "Type of assessment": "Oral examination\nGroup work in PK/PD, which will be evaluated by an individual quiz (30%); Final individual oral examination (Requirement: quiz passed, 70%).",
    "Exam duration": "15 minutes",
    "Aid": "No Aid",
    "Evaluation": "7 step scale , external examiner",
    "Academic prerequisites": "Basic knowledge about organic chemistry and biochemistry",
    "Responsible": "Günther Herbert Johannes Peters , Lyngby Campus, Building 206, Ph. (+45) 4525 2486 , ghp@kemi.dtu.dk",
    "Course co-responsible": "Thomas Ostenfeld Larsen , Building 221, Ph. (+45) 4525 2632 , tol@bio.dtu.dk",
    "Department": "26 Department of Chemistry",
    "Department involved": "22 Department of Health Technology\n27 Department of Biotechnology and Biomedicine",
    "Registration Sign up": "At the Studyplanner",
    "General course objectives": "General course objectives\nTo give the students an understanding of the multi-disciplinary nature of engineering and drug discovery in the pharmaceutical industry involving many disciplines such as: Industrial Biotechnology, Chemical Engineering, Biochemistry, Protein Chemistry, Protein Engineering, Medicinal Chemistry, Pharmacology, Toxicology, Preclinical and Clinical Investigations, Manufacturing, Regulatory Affairs (e.g. GXP), Patent issues, etc.",
    "Learning objectives": "A student who has met the objectives of the course will be able to:\nExplain how in-silico approaches can be used together with bioassays for the discovery, design and development of novel small organic lead compounds.\nDemonstrate general knowledge of assay technologies and their roles and importance in drug discovery and development of e.g. antibiotics.\nExplain the basic principles behind different types of drug-receptor interactions (small molecule-protein and protein-protein interactions).\nMaster calculations of pharmacokinetic and pharmacodynamic properties of drug candidates taking different types of formulations into account.\nExplain the basic mechanisms of drug metabolism and how it relates to toxicology.\nUnderstand the procedures involved in the different phases of preclinical and clinical trials.\nGive a broad account of the up- and down-stream processes involved in biotechnological based drug manufacturing.\nGive a broad account of the analytical methodologies necessary for control of the purity of the final drug product.\nDemonstrate a general knowledge of patent issues and the role of different regulatory authorities at various stages during the drug discovery process.\nGive a basic account of GXP in drug development.\nDemonstrate knowledge of how drug production is planned and executed for both small molecules and biopharmaceuticals.\nGive a broad account of protein stability and protein aggregation.",
    "Content": "The course gives an introduction and overview of the different elements in biopharmaceutical drug discovery and development. Exercises will be given to support the theoretical content. Major case stories are presented in collaboration with Danish pharmaceutical companies.",
    "Course literature": "Biopharmaceuticals, Biochemistry and Biotechnology by Gary Walsh. Editors: John Wiley & Sons Ltd.\nBasic Pharmacokinetics by Sunil S. Jambhekar & Philip J. Breen",
    "Remarks": "Relation to many courses at DTU.",
    "Last updated": "02. maj, 2024"
}